PubMed

Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.

Strauss SM, Astone-Twerell J, Munoz-Plaza CE, Des Jarlais DC, Gwadz M, Hagan H, Osborne A, Rosenblum A.

BMC Health Serv Res. 2007 Mar 8;7:39.PMID: 17346346 [PubMed - indexed for MEDLINE]Related articlesFree article

Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.

Vassilev ZP, Strauss SM, Astone J, Des Jarlais DC.

J Behav Health Serv Res. 2004 Apr-Jun;31(2):208-16.PMID: 15255228 [PubMed - indexed for MEDLINE]Related articles

The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.

Strauss SM, Astone JM, Hagan H, Des Jarlais DC.

J Urban Health. 2004 Mar;81(1):38-47.PMID: 15047782 [PubMed - indexed for MEDLINE]Related articles

Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.

Astone JM, Strauss SM, Hagan H, Des Jarlais DC.

Am J Drug Alcohol Abuse. 2004 Nov;30(4):783-97.PMID: 15624549 [PubMed - indexed for MEDLINE]Related articles

Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.

Strauss SM, Rindskopf DM, Astone-Twerell JM, Des Jarlais DC, Hagan H.

Drug Alcohol Depend. 2006 Jun 9;83(1):15-24. Epub 2005 Nov 9.PMID: 16289523 [PubMed - indexed for MEDLINE]Related articles

Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.

Munoz-Plaza CE, Strauss SM, Astone-Twerwll JM, Des Jarlais DC, Hagan H.

J Psychoactive Drugs. 2006 Sep;38(3):233-41.PMID: 17165366 [PubMed - indexed for MEDLINE]Related articles

Provision of hepatitis C education in a nationwide sample of drug treatment programs.

Astone J, Strauss SM, Vassilev ZP, Des Jarlais DC.

J Drug Educ. 2003;33(1):107-17.PMID: 12773028 [PubMed - indexed for MEDLINE]Related articles

Hepatitis C knowledge among staff in U.S. drug treatment programs.

Strauss SM, Astone-Twerell JM, Munoz-Plaza C, Des Jarlais DC, Gwadz M, Hagan H, Osborne A, Rosenblum A.

J Drug Educ. 2006;36(2):141-58.PMID: 17153514 [PubMed - indexed for MEDLINE]Related articles

Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.

Appel PW, Ellison AA, Jansky HK, Oldak R.

Am J Drug Alcohol Abuse. 2004;30(1):129-53.PMID: 15083558 [PubMed - indexed for MEDLINE]Related articles

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.PMID: 17854731 [PubMed - indexed for MEDLINE]Related articles

Gaps in the drug-free and methadone treatment program response to Hepatitis C.

Strauss SM, Astone J, Vassilev ZP, Des Jarlais DC, Hagan H.

J Subst Abuse Treat. 2003 Jun;24(4):291-7.PMID: 12867202 [PubMed - indexed for MEDLINE]Related articles

A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.

Strauss SM, Astone JM, Jarlais DD, Hagan H.

Drug Alcohol Depend. 2004 Mar 8;73(3):227-36.PMID: 15036545 [PubMed - indexed for MEDLINE]Related articles

A nationwide survey of hepatitis C services provided by drug treatment programs.

Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J.

J Subst Abuse Treat. 2002 Mar;22(2):55-62.PMID: 11932130 [PubMed - indexed for MEDLINE]Related articles

Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.

Grebely J, Genoway K, Khara M, Duncan F, Viljoen M, Elliott D, Raffa JD, DeVlaming S, Conway B.

Int J Drug Policy. 2007 Oct;18(5):437-43. Epub 2007 Apr 27.PMID: 17854734 [PubMed - indexed for MEDLINE]Related articles

Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.

Strauss SM, Astone JM, Des Jarlais DC, Hagan H.

AIDS Patient Care STDS. 2005 Feb;19(2):78-88.PMID: 15716639 [PubMed - indexed for MEDLINE]Related articles

Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

Munoz-Plaza CE, Strauss S, Astone-Twerell J, Jarlais DD, Gwadz M, Hagan H, Osborne A, Rosenblum A.

Int J Drug Policy. 2008 Feb;19(1):71-8. Epub 2007 Aug 6.PMID: 18312822 [PubMed - indexed for MEDLINE]Related articlesFree article

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Doab A, Treloar C, Dore GJ.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S313-20.PMID: 15768340 [PubMed - indexed for MEDLINE]Related articles

The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.

Kwiatkowski CF, Fortuin Corsi K, Booth RE.

Addiction. 2002 Oct;97(10):1289-94.PMID: 12359033 [PubMed - indexed for MEDLINE]Related articles

Knowledge of and interest in hepatitis C treatment at a methadone clinic.

Walley AY, White MC, Kushel MB, Song YS, Tulsky JP.

J Subst Abuse Treat. 2005 Mar;28(2):181-7.PMID: 15780548 [PubMed - indexed for MEDLINE]Related articles

Self-reported hepatitis C virus antibody status and risk behavior in young injectors.

Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS.

Public Health Rep. 2006 Nov-Dec;121(6):710-9.PMID: 17278406 [PubMed - indexed for MEDLINE]Related articlesFree article